What is the best treatment for impetigo in the nose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo in the Nose

Topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment for impetigo in the nose. 1, 2, 3

First-Line Treatment

  • Mupirocin 2% ointment should be applied to the affected area three times daily for 5-7 days 1, 2
  • Clinical efficacy rates with mupirocin are excellent (71-93%) with pathogen eradication rates of 94-100% 3
  • Mupirocin is specifically indicated for the topical treatment of impetigo caused by Staphylococcus aureus and Streptococcus pyogenes 3
  • Clinical improvement should be seen within 3-5 days of starting treatment 4

Second-Line Treatment Options

  • Oral antibiotics should be used when:

    • Impetigo is extensive or involves multiple sites in the nose 1, 2
    • Topical therapy is impractical 2
    • Treatment with topical antibiotics has failed 2
    • Systemic symptoms are present 2
  • For Methicillin-Susceptible S. aureus (MSSA):

    • Dicloxacillin 250 mg four times daily for adults 1
    • Cephalexin 250-500 mg four times daily for adults 1, 2
  • For Methicillin-Resistant S. aureus (MRSA):

    • Clindamycin 300-450 mg three times daily 1, 2
    • Trimethoprim-sulfamethoxazole (TMP-SMX) 1, 2
    • Doxycycline (not for children under 8 years) 1, 2

Diagnostic Considerations

  • Impetigo in the nose typically presents as erythematous papules that rapidly evolve into vesicles and pustules 2
  • Cultures should be obtained if:
    • There is treatment failure 2
    • MRSA is suspected 2
    • In cases of recurrent infections 2

Treatment Duration and Follow-up

  • Topical treatment should be continued for 5-7 days 1, 2
  • Oral antibiotics should be administered for 5-10 days 2
  • Re-evaluate if no improvement after 48-72 hours of therapy 2
  • Lesions should be kept covered when possible to prevent spread 2

Special Considerations for Nasal Impetigo

  • For recurrent furunculosis or impetigo with nasal colonization, application of mupirocin ointment twice daily in the anterior nares for the first 5 days each month can reduce recurrences by approximately 50% 5
  • For persistent or recurrent cases with nasal colonization, clindamycin 150 mg daily for 3 months may decrease subsequent infections by approximately 80% 5

Common Pitfalls and Caveats

  • Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 1
  • Topical disinfectants are not useful in the treatment of impetigo 6
  • Rising rates of bacterial resistance should inform treatment decisions 7
  • Oral erythromycin was historically used but resistance rates are increasing 6, 8

Comparative Effectiveness

  • Topical mupirocin has been shown to be as effective as oral erythromycin in the treatment of impetigo, with superior eradication of S. aureus, including antibiotic-resistant strains 9
  • Mupirocin has a lower incidence of adverse effects compared to oral antibiotics 4, 9

References

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Impetigo Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mupirocin: a new topical therapy for impetigo.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Research

Impetigo.

Advanced emergency nursing journal, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.